|
Resilience Mobile App for Teens and Young Adults With Cancer
RECRUITINGN/ASponsored by Seattle Children's Hospital
Actively Recruiting
PhaseN/A
SponsorSeattle Children's Hospital
Started2023-09-12
Est. completion2027-06-01
Eligibility
Age12 Years – 25 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT05842902
Summary
The goal of this pilot trial is to examine whether a mobile app version of the Promoting Resilience in Stress Management (PRISM) intervention is acceptable, easy to use, and helps improve quality of life and mental health symptoms.
Eligibility
Age: 12 Years – 25 YearsHealthy volunteers accepted
Inclusion Criteria: * Age 12-25 years * Diagnosis of new malignancy within 12 months of enrollment treated with chemotherapy and/or radiation therapy at Seattle Children's Hospital (SCH) * Patient able to speak/read/write English or Spanish language * Cognitively able to participate in mHealth psychosocial intervention and interactive interviews Exclusion Criteria: * Patient refusal to participate (any age), or parental refusal to participate for patients less than 18 years of age * Patients with diagnosis of malignancy \>12 months * Patients with relapsed, recurrent, or refractory disease * Patient without chemotherapy and/or radiation therapy as part of cancer treatment (e.g., surgical resection only patients are not-eligible) * Cognitively or physically unable to participate in mHealth psychosocial intervention and surveys
Conditions1
Cancer
Locations1 site
Seattle Children's Hospital
Seattle, Washington, 98105
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorSeattle Children's Hospital
Started2023-09-12
Est. completion2027-06-01
Eligibility
Age12 Years – 25 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT05842902